Group One Trading, L.P. Bio Atla, Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Bio Atla, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 10,440 shares of BCAB stock, worth $8,247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,440
Previous 21,224
50.81%
Holding current value
$8,247
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BCAB
# of Institutions
42Shares Held
13.5MCall Options Held
20.7KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.84MShares$3.82 Million1.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.41 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.49MShares$1.18 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$1.09 Million0.03% of portfolio
-
Black Rock Inc. New York, NY792KShares$625,3320.0% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $28.7M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...